Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenedrive Regulatory News (GDR)

Share Price Information for Genedrive (GDR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.625
Bid: 1.60
Ask: 1.65
Change: 0.025 (1.56%)
Spread: 0.05 (3.125%)
Open: 1.60
High: 1.675
Low: 1.60
Prev. Close: 1.60
GDR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on CFO Appointment

29 Nov 2016 07:00

RNS Number : 3503Q
Genedrive PLC
29 November 2016
 

 

 

For release: 29 November 2016

 

genedrive plc ("genedrive" or the "Company")

 

Update on CFO Appointment

 

genedrive plc (LSE: GDR), the near patient molecular diagnostics company, is pleased to announce that, following his appointment as Chief Financial Officer and a Director of the Company as announced on 21 September 2016, Matthew Fowler will join genedrive plc on 13 December 2016.

 

Matthew joins genedrive plc with over 15 years of experience in senior positions in the manufacturing, power and support services industries. Prior to joining genedrive plc, Matthew spent eight years as Group Financial Controller of Scapa Group plc, a multinational manufacturing AIM-quoted business. At Scapa Group plc, Matthew was responsible for shaping and managing finance within the Group as well as strategy development and other core processes.

 

Before joining Scapa Group plc, Matthew spent three years at British Nuclear Group as Finance Manager where he managed the corporate centre's finance team and was responsible for planning, reporting and accounting. Matthew trained and qualified in the audit department of Deloitte & Touche.

- Ends -

 

For further details please contact:

genedrive plc

David Budd: CEO +44 (0)161 989 0245

 

Peel Hunt LLP

James Steel +44 (0)207 418 8900

Oliver Jackson

 

Consilium Strategic Communications

Chris Gardner +44 (0)203 709 5700

Matthew Neal

Laura Thornton

genedrive@consilium-comms.com 

 

 

Notes to Editors

 

genedrive plc is a molecular diagnostics company developing and commercialising a low cost, rapid, versatile, simple to use and robust point of need diagnostics platform for the diagnosis of infectious diseases and for use in patient stratification (genotyping), pathogen detection and other indications. The Genedrive® platform and MTB/RIF test have been launched in India and a Genedrive® HCV test has been successfully assessed by the Institut Pasteur, Paris.

 

genedrive plc was formerly Epistem plc and continues to provide contract research services to drug development companies under the Epistem brand name.

 

Further details can be found at: www.genedriveplc.com and www.genedrive.com 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAPGGGUGUPQGMR
Date   Source Headline
30th Mar 20177:00 amRNSInterim Results
27th Mar 20177:00 amRNSHCV Assay submitted for CE IVD Certification
24th Mar 20177:00 amRNSNotice of Interim Results
8th Mar 20177:00 amRNSSuccessful Clinical Results - Genedrive HCV Assay
20th Feb 20177:00 amRNSDirector/PDMR Shareholding
6th Feb 20175:53 pmRNSHoldings in Company
27th Jan 20177:00 amRNSTrading Update
16th Jan 20177:00 amRNSUpdate on US Department of Defense Programme
23rd Dec 201610:48 amRNSDirector/PDMR Shareholding
30th Nov 20162:16 pmRNSResult of AGM
29th Nov 20167:00 amRNSUpdate on CFO Appointment
17th Nov 20167:00 amRNSCE-IVD Certification for Human Genotyping Test
11th Nov 20165:47 pmRNSNotice of AGM
11th Oct 20167:00 amRNSPreliminary Results for the year end 30 June 2016
21st Sep 20167:00 amRNSNotice of Preliminary Results
21st Sep 20167:00 amRNSAppointment of Chief Financial Officer
10th Aug 20167:00 amRNSGenedrive Assay used in STOP-HCV-1 Clinical Trial
2nd Aug 20167:00 amRNSTrading Update
29th Jul 20165:58 pmRNSTotal Voting Rights
25th Jul 20167:00 amRNSRe change of name, TIDM and website address
14th Jul 20163:56 pmRNSHolding(s) in Company
14th Jul 20168:19 amRNSDirector/PDMR Shareholding
14th Jul 20168:18 amRNSHolding(s) in Company
13th Jul 20162:49 pmRNSHolding(s) in Company
12th Jul 20169:05 amRNSDirector/PDMR Shareholding
11th Jul 201611:34 amRNSResult of General Meeting and Change of Name
23rd Jun 20164:54 pmRNSPosting of Shareholder Circular
23rd Jun 20167:00 amRNSProposed Placing and Amendment to GHIF Bond
7th Jun 20167:00 amRNSBusiness Update
3rd May 20167:00 amRNSSuccessful Clinical Trial of Genedrive®
18th Apr 20167:00 amRNSEpistem Begins Full Commercial Launch of Genedrive
7th Apr 20164:54 pmRNSDirector/PDMR Shareholding
31st Mar 20167:00 amRNSInterim Results
21st Mar 20167:42 amRNSFunding award from US Department of Defense
19th Feb 20167:00 amRNSUpdate on CEO Appointment
18th Feb 20167:00 amRNSAnnounces Successful Assessment of Genedrive
13th Jan 20167:00 amRNSEpistem Appoints David Budd as CEO
16th Dec 20152:18 pmRNSDirector/PDMR Shareholding
16th Dec 20152:11 pmRNSResult of AGM
26th Nov 20154:41 pmRNSHolding(s) in Company
24th Nov 20153:28 pmRNSNotice of AGM
24th Nov 20152:07 pmRNSHolding(s) in Company
28th Oct 20157:00 amRNSPreliminary Results for year ended 30 June 2015
26th Oct 20157:00 amRNSEpistem Holdings Plc - Board Change
20th Oct 20157:00 amRNSNotice of Preliminary Results
15th Oct 20157:30 amRNSDirector/PDMR Shareholding
4th Aug 20157:00 amRNSPre-Close Trading Update and Board Changes
15th Jun 201512:17 pmRNSHolding(s) in Company
8th Jun 20154:49 pmRNSIssuance of Shares
18th May 201512:45 pmRNSNIH Response to UMB proposal

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.